chitosan has been researched along with Migraine Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bukka, R; Khezri, FANZ; Lakshmi, CSR; Nargund, SL; Nidhi, M | 1 |
| Kaur, G; Kaur, K | 1 |
| Hansraj, GP; Kumar, P; Singh, SK | 1 |
| Girotra, P; Kumar, A; Singh, SK; Thakur, A | 1 |
| Harshada, SD; Mundada, AS | 1 |
| Alhalaweh, A; Bandiera, P; Beggiato, S; Dalpiaz, A; Ferraro, L; Gavini, E; Giunchedi, P; Marchetti, N; Rassu, G; Velaga, S | 1 |
6 other study(ies) available for chitosan and Migraine Disorders
| Article | Year |
|---|---|
Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
Topics: Administration, Intranasal; Animals; Brain; Chitosan; Chromatography, Liquid; Disease Models, Animal; Male; Migraine Disorders; Nanoparticles; Oxazolidinones; Particle Size; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tryptamines | 2020 |
Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Topics: Administration, Intranasal; Brain; Chemistry, Pharmaceutical; Chitosan; Chondroitin Sulfates; Drug Delivery Systems; Humans; Microscopy, Electron, Scanning; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2013 |
Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential.
Topics: Animals; Behavior, Animal; Brain; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Disease Models, Animal; Drug Carriers; Drug Liberation; Male; Mice; Migraine Disorders; Nanoparticles; Rats; Serotonin 5-HT1 Receptor Agonists; Spectroscopy, Fourier Transform Infrared; Sumatriptan; Thermogravimetry; X-Ray Diffraction | 2015 |
Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation.
Topics: Animals; Bradykinin; Brain; Chitosan; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Grooming; Hyperalgesia; Male; Mice; Migraine Disorders; Molecular Docking Simulation; Molecular Targeted Therapy; Nanoparticles; Nystatin; Particle Size; Photophobia; Protein Conformation; Software | 2017 |
Formulation Development and Evaluation of Lyophilized Nasal Inserts for Migraine Treatment.
Topics: Administration, Intranasal; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Freeze Drying; Humans; Migraine Disorders; Patents as Topic; Polysaccharides, Bacterial | 2017 |
Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
Topics: Adhesives; Administration, Intranasal; Administration, Intravenous; Animals; Area Under Curve; Brain; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Glutamic Acid; Hypromellose Derivatives; Migraine Disorders; Nasal Mucosa; Oxazolidinones; Permeability; Polymers; Powders; Swine; Tryptamines | 2013 |